2Effect of blood pressure control on diabetic microvascular complication in patients with hypertension in patients with hypertension and type 2diabetes. Diabetes care, 2003, suppl: B54 - 65. 被引量：1
3Davis BR, Fuberg CD, Wright JJ, et al. 2002; ALLHAT: Setting the record straight. Ann Intern Med, 2004, 141:39-46. 被引量：1
4ALLHAT: Collaborative research group. JAMA, 2002, 288:2981-97. 被引量：1
5Outcomes in hypertensive patients at high cardiovascular amlodipine:the UALUE randomized trial. Lancet, 2004,19:363(9426) :2022 - 31. 被引量：1
6Effects of ACE inhibitors, calcium antagonists and other blood - pressure- lowering drugs: results of prospectively designed overviews of ranndomised trials Blood pressure Lowering Trials. Collaboration Lancet, 2000, 355:1955-64. 被引量：1
9Nissen SE, Tuscou EM, Libby P, et al. Effect of antihypertensive agents on cardiovascularevents in patients with coronary disease and normal blood pressure:the CAMELOT study: a randomized controlled trial. JAMA, 2004, Nov 10:292(18):2217-25. 被引量：1
2Unda S, Meredith PA, Howic CA, et al. A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive[J].Subject Br J Clini Pharm,1993,36:561. 被引量：1
9The Allhat officers and coordinators for the Allhat collaborative research group.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial(ALLHAT)[J].JAMA,2002,288(23):2981-2997. 被引量：1
10Julius S,Kjeldsen SE,Weber M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[J].Lancet,2004,363(9426):2022-2031. 被引量：1
